132 results match your criteria: "Centre for Individualized Medicine[Affiliation]"

Proteomic exploration of common pathophysiological pathways in diabetes and cardiovascular disease.

ESC Heart Fail

December 2020

Department of Clinical Sciences, Lund University, Clinical Research Center, Inga Marie Nilssons gata 47, Malmö, 20502, Sweden.

Aims: The epidemiological association between diabetes and cardiovascular disease is well established, but the pathophysiological link is complex and multifactorial. We investigated seven proteins, previously linked to incident diabetes mellitus, and their association with cardiovascular disease and mortality.

Methods And Results: Plasma samples from 1713 individuals from the Swedish population-based Malmö Preventive Project (mean age 67.

View Article and Find Full Text PDF

Hypertension guidelines recommend that blood pressure (BP) should be measured using a monitor that has passed validation testing for accuracy. BP monitors that have not undergone rigorous validation testing can still be cleared by regulatory authorities for marketing and sale. This is the situation for most BP monitors worldwide.

View Article and Find Full Text PDF

Purpose: To determine the occurrence of physiological significant coronary artery disease (CAD) by coronary CT angiography (CTA) derived fractional flow reserve (FFR) in asymptomatic patients with a new diagnosis (<1 year) of type-2 diabetes mellitus (T2DM).

Methods: FFR-analysis was performed from standard acquired coronary CTA data sets. The per-patient minimum distal FFR-value (d-FFR) in coronary vessels (diameter ⩾1.

View Article and Find Full Text PDF

Hyperlipidemia does not affect development of elastase-induced abdominal aortic aneurysm in mice.

Atherosclerosis

October 2020

Stanford University, Department of Cardiovascular Medicine, Stanford, CA, United States; Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark; Centre for Individualized Medicine in Arterial Diseases, Odense University Hospital, Odense, Denmark; Unit of Cardiovascular and Renal Research, Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark.

Background And Aims: Hyperlipidemia is a suggested risk factor for abdominal aortic aneurysm (AAA). However, whether hyperlipidemia is causally involved in AAA progression remains elusive. Here, we tested the hypothesis that hyperlipidemia aggravates AAA formation in the widely used porcine pancreatic elastase (PPE) model of AAA in mice with varying levels of plasma lipids.

View Article and Find Full Text PDF

Objective: Pregnancy-associated plasma protein-A (PAPP-A) has been suggested as a proatherogenic enzyme by its ability to locally increase insulin-like growth factor (IGF) activity through proteolytic cleavage of IGF binding protein-4 (IGFBP-4). Recently, stanniocalcin-2 (STC2) was discovered as an inhibitor of PAPP-A. This study aimed to investigate IGFBP-4, PAPP-A, and STC2 as local regulators of IGF bioactivity in the cardiac microenvironment by comparing levels in the pericardial fluid with those in the circulation of patients with cardiovascular disease.

View Article and Find Full Text PDF

Background: An abdominal aortic aneurysm (AAA) is a progressive chronic dilatation of the abdominal aorta with terminally rupture when the aortic wall is so weakened that aortic wall stress exceeds wall strength. No effective medical treatment exists so far. We aimed to test whether intraluminal admission of Penta-Galloyl Glucose (PGG) treatment in a rodent AAA model could hold the potential to inhibit aneurysmal progression.

View Article and Find Full Text PDF

It is unclear whether 12-lead ECG employing standard criteria for left ventricular hypertrophy (LVH) provides similar information with respect to long-term cardiovascular risk as echocardiography. The authors performed a retrospective cohort study of 1376 individuals without cardiovascular disease, who underwent ECG (LVH defined using the Sokolow-Lyon voltage combination (>35 mm) or the Cornell voltage-duration product (>2440 mm × ms)) and echocardiography (LVH defined as LV mass index (LVMI) >95 g/m for women and >115 g/m for men). The prognostic ability of LVH was assessed in Cox regression models adjusted for age, sex, smoking, systolic blood pressure, total cholesterol, antihypertensive medication, and fasting glucose.

View Article and Find Full Text PDF

Self-home blood pressure (BP) monitoring is recommended to guide clinical decisions on hypertension and is used worldwide for cardiovascular risk management. People usually make their own decisions when purchasing BP devices, which can be made online. If patients purchase nonvalidated devices (those not proven accurate according to internationally accepted standards), hypertension management may be based on inaccurate readings resulting in under- or over-diagnosis or treatment.

View Article and Find Full Text PDF

Objective: Atrial fibrillation (AF) is the most common arrhythmia and associated with increased morbidity and mortality. Its increasing prevalence calls for novel biomarkers to identify underlying pathophysiological mechanisms as well as patients at risk.

Methods: Plasma samples from 1694 individuals from the Swedish population-based Malmö Preventive Project (mean age 69.

View Article and Find Full Text PDF

Aim: The prevalence and mortality of abdominal aortic aneurysms (AAA) has been reported to decline. The aim of this study is to compare survival, prevalence, and repair rate of AAA in Denmark in the 1990s, the 2000s and the 2010s - and to examine any change in factors known to influence the prevalence.

Methods: Baseline status and up to 5-year outcomes of 34,079 general population men aged 65-74 were obtained from three RCTs; the Viborg study (1994-1998, n=4,860), the Viborg Vascular (VIVA) trial (2008-2011, n=18,748), and the Danish Cardiovascular (DANCAVAS) trial (2015-2018, n=10,471).

View Article and Find Full Text PDF

Association between antecedent blood pressure, hypertension-mediated organ damage and cardiovascular outcome.

Blood Press

August 2020

Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, Odense, University of Southern Denmark, Odense, Denmark.

The objective of this study was to test if combining antecedent systolic blood pressure (SBP) with traditional risk factors and hypertension-mediated organ damage (HMOD) improves risk stratification for subsequent cardiovascular disease. 1910 subjects participated in this study. Antecedent SBP was defined as the average of measurements obtained in 1982 and in 1987.

View Article and Find Full Text PDF

Reply.

J Hypertens

April 2020

Third Department of Medicine, Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Sotiria Hospital, Athens, Greece.

View Article and Find Full Text PDF

[Lancet Commission on Hypertension Group position statement on the global improvement of accuracy standards for devices that measure blood pressurePosicionamento do Grupo da sobre a melhoria global dos padrões de acurácia para aparelhos que medem a pressão arterial].

Rev Panam Salud Publica

March 2020

Hypertension Center STRIDE-7 Universidad Nacional y Kapodistríaca de Atenas, Facultad de Medicina, Tercer Departamento de Medicina, Hospital Sotiria Atenas Grecia Hypertension Center STRIDE-7, Universidad Nacional y Kapodistríaca de Atenas, Facultad de Medicina, Tercer Departamento de Medicina, Hospital Sotiria, Atenas, Grecia.

Article Synopsis
  • The Lancet Commission on Hypertension emphasizes the importance of improving blood pressure measurement accuracy by using validated devices, as many currently available devices lack proper accuracy testing.
  • Weak regulations allow inaccurate devices to be sold without validation, leading to poor hypertension diagnosis and treatment globally.
  • The Commission urges for mandatory independent validation of BP devices and recommends developing standards for new technologies, while supporting the establishment of accessible lists of accurate devices for consumers and healthcare professionals.
View Article and Find Full Text PDF
Article Synopsis
  • - The study proposes a new method for estimating genetic parameters related to diseases using large health datasets, focusing on temporal disease prevalence curves and low-dimensional embeddings instead of traditional genetic data.
  • - Researchers provide over eleven thousand heritability estimates across various study types and calculate more than six hundred thousand genetic, environmental, and phenotypic correlations.
  • - Key findings reveal five general patterns of disease curve shapes, a trend showing lower prevalence for early-onset diseases compared to late-onset, and a negative correlation between disease onset age and heritability.
View Article and Find Full Text PDF

Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure.

J Hypertens

January 2020

Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia The Conway Institute, University College Dublin, Dublin, Ireland University of Tennessee Health Science Center, Memphis, Tennessee, USA Hypertension in Africa Research Team, Medical Research Council Unit for Hypertension and Cardiovascular Disease, North-West University, Potchefstroom, South Africa Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK Department of Internal Medicine, Holbaek Hospital, Holbaek Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, University of Southern Denmark, Odense, Denmark Foundation-Medical Research Institutes, Geneva, Switzerland Medaval Ltd., Dublin, Ireland Hypertension League of Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil Vascular Biology and Hypertension Group, University of Alabama at Birmingham, Birmingham, Alabama, USA Department of Medicine, Physiology and Pharmacology and Community Health Sciences, O'Brien Institute for Public Health and Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia American Heart Association, Dallas, Texas, USA Sydney Medical School, University of Sydney and Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia Department of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970 and University Paris Descartes, Paris, France FOSCAL, Instituto Masira, Facultad de Ciencias de la Salud, UDES, Bucaramanga, Colombia Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Oxford, UK Cardiovascular & Hormonal Research Laboratory, Department of Cardiology & Kolling Institute, Royal North Shore Hospital and Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia Department of Non Communicable and Mental Health, Pan American Health Organization, Washington, District of Columbia Department of Medicine, University of Alberta, Edmonton, Alberta, Canada Studium Patavinum, University of Padova, Padua Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano, IRCCS, San Luca Hospital Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy Imperial Clinical Trials Unit, Imperial College London, London, UK American Medical Association, Improving Health Outcomes, Chicago, Illinois Department of Medicine (Cardiology), Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York The James J. Peters VA Medical Center, Bronx, New York, USA Cardiology Unit, Department of Medicine, University of Padova, Town Hospital of Cittadella, Padova Department of Medical, Surgical, and Experimental Sciences, University of Sassari, Sassari, Italy Hypertension League, Department of Cardiology, Federal University of Goiás, Goiânia, Brazil Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China Steno Diabetes Center Copenhagen, Gentofte, Denmark Third Department of Medicine, Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Sotiria Hospital, Athens, Greece.

: The Lancet Commission on Hypertension identified that a key action to address the worldwide burden of high blood pressure (BP) was to improve the quality of BP measurements by using BP devices that have been validated for accuracy. Currently, there are over 3000 commercially available BP devices, but many do not have published data on accuracy testing according to established scientific standards. This problem is enabled through weak or absent regulations that allow clearance of devices for commercial use without formal validation.

View Article and Find Full Text PDF

Background: Heart failure is a highly prevalent disease with a global prevalence of 37 million, and the prevalence is increasing. Patients with heart failure are at an increased risk of death and morbidity. Traditionally, patients with heart failure have been treated with a beta-blocker in addition to an inhibitor of the renin-angiotensin-aldosterone system.

View Article and Find Full Text PDF

The objective of this study was to determine if plasma CCN2 is associated with abdominal aorta aneurysm (AAA), and future need for AAA repair, and further to assess the potential clinical value of CCN2 in predicting disease outcome. CCN2 was quantified in plasma samples obtained from a cohort of 679 men aged 65-74 at initial ultrasound screening for AAA in the Viborg Vascular (VIVA) screening trial. Plasma CCN2 was correlated with need for future surgical repair in the whole study population (HR = 1.

View Article and Find Full Text PDF

PAPP-A and the IGF system in atherosclerosis: what's up, what's down?

Am J Physiol Heart Circ Physiol

November 2019

Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.

Pregnancy-associated plasma protein-A (PAPP-A) is a metalloproteinase with a well-established role in releasing bioactive insulin-like growth factor-1 (IGF-1) from IGF-binding protein-2, -4, and -5 by proteolytic processing of these. The IGF system has repeatedly been suggested to be involved in the pathology of atherosclerosis, and both PAPP-A and IGF-1 are proposed biomarkers and therapeutic targets for this disease. Several experimental approaches based on atherosclerosis mouse models have been undertaken to obtain causative and mechanistic insight to the role of these molecules in atherogenesis.

View Article and Find Full Text PDF

Atrial fibrillation (AF) is associated with increased cardiovascular risk and the incidence increases with age, hypertension and left ventricular hypertrophy (LVH). Reducing in-treatment systolic blood pressure (SBP) prevents new-onset AF but has previously not been studied in patients with isolated systolic hypertension (ISH). We aimed to investigate the effect on preventing new-onset AF by decreased in-treatment SBP in patients with ISH compared to patients with non-ISH.

View Article and Find Full Text PDF

: High blood pressure (BP) is a highly prevalent modifiable cause of cardiovascular disease, stroke, and death. Accurate BP measurement is critical, given that a 5-mmHg measurement error may lead to incorrect hypertension status classification in 84 million individuals worldwide. This position statement summarizes procedures for optimizing observer performance in clinic BP measurement, with special attention given to low-to-middle-income settings, where resource limitations, heavy workloads, time constraints, and lack of electrical power make measurement more challenging.

View Article and Find Full Text PDF

Multiplex proteomic platforms provide excellent tools for investigating associations between multiple proteins and disease (e.g., diabetes) with possible prognostic, diagnostic, and therapeutic implications.

View Article and Find Full Text PDF

Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose ≥ 155 mg/dl (8.6 mmol/L).

Diabetes Res Clin Pract

December 2018

Institut d'Investigacions Biomèdiques August Pi I Sunyer and Centro de Investigación Biomedica en Red de Diabetes y Enfermedades Metabólicas Asociadas, Barcelona, Spain; Department of Cardiovascular and Metabolic Diseases, Istituto Ricerca Cura Carattere Scientifico Multimedica, Sesto, San Giovanni, MI, Italy.

Many individuals with prediabetes, as presently defined, will progress to diabetes (T2D) despite the considerable benefit of lifestyle modification. Therefore, it is paramount to screen individuals at increased risk with a more sensitive method capable of identifying prediabetes at an even earlier time point in the lengthy trajectory to T2D. This petition reviews findings demonstrating that the 1-hour (1-h) postload plasma glucose (PG) ≥ 155 mg/dl (8.

View Article and Find Full Text PDF

Introduction: Aortic stenosis is a common heart valve disease, and due to the growing elderly population, the prevalence is increasing. The disease is progressive with increasing calcification of the valve cusps. A few attempts with medical preventive treatment have failed; thus, presently, the only effective treatment of aortic stenosis is surgery.

View Article and Find Full Text PDF

Objective: Arterial ageing is characterized by increasing arterial stiffness as measured by pulse wave velocity (PWV). This process is enhanced in participants with early vascular ageing (EVA), but slowed in participants with healthy vascular ageing (HVA). We aimed to describe characteristics of EVA and HVA in a transcontinental study including 11 cohorts.

View Article and Find Full Text PDF